Elisabeth Arnold

683 total citations
27 papers, 561 citations indexed

About

Elisabeth Arnold is a scholar working on Pediatrics, Perinatology and Child Health, Infectious Diseases and Oncology. According to data from OpenAlex, Elisabeth Arnold has authored 27 papers receiving a total of 561 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pediatrics, Perinatology and Child Health, 6 papers in Infectious Diseases and 5 papers in Oncology. Recurrent topics in Elisabeth Arnold's work include Epilepsy research and treatment (4 papers), Pharmacological Effects and Toxicity Studies (4 papers) and Infectious Encephalopathies and Encephalitis (4 papers). Elisabeth Arnold is often cited by papers focused on Epilepsy research and treatment (4 papers), Pharmacological Effects and Toxicity Studies (4 papers) and Infectious Encephalopathies and Encephalitis (4 papers). Elisabeth Arnold collaborates with scholars based in Denmark, Sweden and Norway. Elisabeth Arnold's co-authors include Caroline Ellis‐Hill, Anne Bruton, Widmar Tanner, Val R. Beasley, Tom Bergan, I. Magnussen, Benny Johansson, Erling N. Petersen, Claus Larsen and Henning Bundgaard and has published in prestigious journals such as FEBS Letters, International Journal of Pharmaceutics and Biochemical Pharmacology.

In The Last Decade

Elisabeth Arnold

27 papers receiving 513 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elisabeth Arnold Denmark 11 133 120 84 65 51 27 561
Barry G. Woodcock Germany 17 66 0.5× 214 1.8× 99 1.2× 51 0.8× 22 0.4× 65 826
Rudolf Pfab Germany 17 102 0.8× 88 0.7× 61 0.7× 54 0.8× 143 2.8× 31 617
Paul Mahieu Belgium 20 164 1.2× 127 1.1× 89 1.1× 101 1.6× 122 2.4× 87 1.2k
Lidia J. Notarianni United Kingdom 18 42 0.3× 123 1.0× 210 2.5× 28 0.4× 24 0.5× 48 1.0k
Jacek Sein Anand Poland 14 92 0.7× 101 0.8× 45 0.5× 55 0.8× 57 1.1× 163 781
Nigel S. Baber United Kingdom 6 49 0.4× 166 1.4× 117 1.4× 45 0.7× 22 0.4× 16 912
John E. Stambaugh United States 18 31 0.2× 146 1.2× 126 1.5× 75 1.2× 11 0.2× 34 767
A. Thuillier France 13 48 0.4× 102 0.8× 110 1.3× 59 0.9× 7 0.1× 30 769
Howard Wey United States 17 66 0.5× 195 1.6× 66 0.8× 22 0.3× 41 0.8× 56 968
Stephen M. Holliday New Zealand 8 83 0.6× 73 0.6× 65 0.8× 89 1.4× 5 0.1× 11 591

Countries citing papers authored by Elisabeth Arnold

Since Specialization
Citations

This map shows the geographic impact of Elisabeth Arnold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabeth Arnold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabeth Arnold more than expected).

Fields of papers citing papers by Elisabeth Arnold

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabeth Arnold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabeth Arnold. The network helps show where Elisabeth Arnold may publish in the future.

Co-authorship network of co-authors of Elisabeth Arnold

This figure shows the co-authorship network connecting the top 25 collaborators of Elisabeth Arnold. A scholar is included among the top collaborators of Elisabeth Arnold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabeth Arnold. Elisabeth Arnold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Weitensfelder, Lisbeth, et al.. (2023). Areas of Individual Consumption Reduction: A Focus on Implemented Restrictions and Willingness for Further Cut-Backs. Sustainability. 15(6). 4956–4956. 3 indexed citations
2.
Arnold, Elisabeth, Anne Bruton, & Caroline Ellis‐Hill. (2006). Adherence to pulmonary rehabilitation: A qualitative study. Respiratory Medicine. 100(10). 1716–1723. 137 indexed citations
3.
Arnold, Elisabeth, et al.. (1991). 2,4-D toxicosis.II: A pilot study of clinical pathologic and electroencephalographic effects and residues of 2,4-D in orally dosed dogs.. PubMed. 33(5). 446–9. 8 indexed citations
4.
Beasley, Val R., Elisabeth Arnold, Richard Lovell, & Alan J. Parker. (1991). 2,4-D toxicosis. I: A pilot study of 2,4-dichlorophenoxyacetic acid- and dicamba-induced myotonia in experimental dogs.. PubMed. 33(5). 435–40. 13 indexed citations
5.
Johansson, Benny, Erling N. Petersen, & Elisabeth Arnold. (1989). Diethylthiocarbamic acid methyl ester. Biochemical Pharmacology. 38(7). 1053–1059. 33 indexed citations
6.
Arnold, Elisabeth & Val R. Beasley. (1989). The pharmacokinetics of chlorinated phenoxy acid herbicides: a literature review.. PubMed. 31(2). 121–5. 40 indexed citations
7.
Arnold, Elisabeth & Andrejs Skaburskis. (1989). Measuring Ontario's increasing housing affordability problem. Social Indicators Research. 21(5). 501–515. 9 indexed citations
8.
Vinge, Ellen, et al.. (1986). Pharmacokinetics of14C‐Fenflumizole after Intravenous Administration to Man. Acta Pharmacologica et Toxicologica. 58(5). 355–362. 2 indexed citations
9.
Orlean, Peter, Elisabeth Arnold, & Widmar Tanner. (1985). Apparent inhibition of glycoprotein synthesis by S.cerevisiae mating pheromones. FEBS Letters. 184(2). 313–317. 17 indexed citations
10.
Vinge, Ellen, et al.. (1985). Single Intravenous and Oral Doses of Fenflumizole: Pharmacokinetics and Effects on Prostanoid Formation. Acta Pharmacologica et Toxicologica. 57(2). 121–129. 2 indexed citations
11.
Ck, Axelsson, et al.. (1985). Absorption of metronidazole suppositories in patients with postoperative ileus.. PubMed. 32(2). 134–7. 1 indexed citations
12.
Arnold, Elisabeth & Widmar Tanner. (1982). An obligatory role of protein glycosylation in the life cycle of yeast cells. FEBS Letters. 148(1). 49–53. 60 indexed citations
13.
Myhre, Erik, et al.. (1982). Pharmacokinetics of Methyldopa in Renal Failure and Bilaterally Nephrectomized Patients. Scandinavian Journal of Urology and Nephrology. 16(3). 257–263. 5 indexed citations
14.
Bergan, Tom, et al.. (1980). Comparison of metronidazole assay by microbiological and chemical methods.. PubMed. 2(3). 145–50. 2 indexed citations
15.
Bergan, Tom & Elisabeth Arnold. (1980). Pharmacokinetics of Metronidazole in Healthy Adult Volunteers after Tablets and Suppositories. Chemotherapy. 26(4). 231–241. 29 indexed citations
16.
Steiness, Eva, et al.. (1978). Serum Diazepam and Serum Creatine Kinase after Intra‐muscular Injection of Diazepam in Two Different Vehicles. Acta Anaesthesiologica Scandinavica. 22(s66). 91–95. 6 indexed citations
17.
Myhre, E, et al.. (1977). Pharmacokinetics of methyldopa in healthy man. European Journal of Clinical Pharmacology. 12(2). 117–123. 22 indexed citations
18.
Arnold, Elisabeth, et al.. (1976). Farmakokinetiske undersøgelser af14C-mærket disulfiram(Antabus®). En præliminaer undersøgelse. Nordisk Psykiatrisk Tidsskrift. 30(7). 507–511. 2 indexed citations
19.
Arnold, Elisabeth. (1975). A Simple Method for Determining Diazepam and Its Major Metabolites in Biological Fluids: Application in Bioavailability Studies. Acta Pharmacologica et Toxicologica. 36(4). 335–352. 46 indexed citations
20.
Arnold, Elisabeth, E Hvidberg, & Søren Rasmussen. (1969). Methodological Studies of the Distribution of Hydroxyproline in Human Serum. Scandinavian Journal of Clinical and Laboratory Investigation. 24(3). 231–235. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Barry G. Woodcock Breakdown of academic impact, for papers by Rudolf Pfab Breakdown of academic impact, for papers by Paul Mahieu Breakdown of academic impact, for papers by Lidia J. Notarianni Breakdown of academic impact, for papers by Jacek Sein Anand Breakdown of academic impact, for papers by Nigel S. Baber Breakdown of academic impact, for papers by John E. Stambaugh Breakdown of academic impact, for papers by A. Thuillier Breakdown of academic impact, for papers by Howard Wey Breakdown of academic impact, for papers by Stephen M. Holliday
Rankless by CCL
2026